Compounds > 5,7-dinitroquinoxaline-2,3-dione
Page last updated: 2024-09-03

5,7-dinitroquinoxaline-2,3-dione and strychnine

5,7-dinitroquinoxaline-2,3-dione has been researched along with strychnine in 1 studies

Compound Research Comparison

Studies
(5,7-dinitroquinoxaline-2,3-dione)		Trials
(5,7-dinitroquinoxaline-2,3-dione)		Recent Studies (post-2010)
(5,7-dinitroquinoxaline-2,3-dione)		Studies
(strychnine)		Trials
(strychnine)		Recent Studies (post-2010) (strychnine)
5004,77816490

Protein Interaction Comparison

ProteinTaxonomy5,7-dinitroquinoxaline-2,3-dione (IC50)strychnine (IC50)
Glycine receptor subunit alpha-1Homo sapiens (human)0.1843
Glycine receptor subunit betaHomo sapiens (human)0.2871

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drejer, J; Honoré, T; Jensen, LH; Sheardown, MJ; Stidsen, CE1

Other Studies

1 other study(ies) available for 5,7-dinitroquinoxaline-2,3-dione and strychnine

ArticleYear
A potent antagonist of the strychnine insensitive glycine receptor has anticonvulsant properties.
    European journal of pharmacology, 1989, Dec-19, Volume: 174, Issue:2-3

    Topics: Animals; Anticonvulsants; Aspartic Acid; Cerebral Cortex; Cortical Spreading Depression; Female; gamma-Aminobutyric Acid; Glycine; In Vitro Techniques; Male; Mice; Mice, Inbred DBA; N-Methylaspartate; Pregnancy; Pyrrolidinones; Quinoxalines; Rats; Receptors, Glycine; Receptors, Neurotransmitter; Seizures; Strychnine

1989